Recurrent herpes simplex virus type I (HSV-1) infection is a major cause of viral induced blindness. Although the HSV-1 LAT gene is essential for efficient spontaneous reactivation, it remains unclear whether LAT's main latency related function takes place during establishment of latency or reactivation from latency. Although LAT can enhance the rate at which latency is established by 2-3 fold, it can enhances spontaneous reactivation by up to 10-fold. In addition, a mutation in a gene other than LAT has been shown to reduce establishment of latency by 20-fold without altering spontaneous reactivation. We hypothesize that LAT has an important function during the reactivation stage of the HSV-1 latency reactivation cycle. This would make LAT an excellent target for therapeutic intervention to block recurrent disease, and would have tremendous clinical significance.
Our specific aim i s to construct and then infect rabbits with an HSV-1 mutant in which LAT is expressed only when Dox is present.in the rabbit's water supply. Dox will be fed either (i)just prior to and then throughout the first 21 days of infection (LAT will be active only during the time of establishment of latency) or (ii)continuously from days 22 to 60 post infection (pi) (LAT will be active only during the time of reactivation from latency). Spontaneous reactivation will be determined from 30 to 60 days pi. We expect these two complementary experiments to show that LAT is important during reactivation. Thus, (i)when LAT is active only during establishment we expect spontaneous reactivation to be reduced to LAT null mutants levels; and (10when LAT is active only during reactivation we expect wild type spontaneous reactivation levels. These results would confirm that LAT is important at the reactivation step and suggest that blocking LAT's function would be an outstanding therapeutic approach for eliminating or reducing recurrent HSV-1 ocular disease in individuals with a history of recurrent ocular HSV-1.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Research Grants (R03)
Project #
5R03EY013701-03
Application #
6524800
Study Section
Special Emphasis Panel (ZEY1-VSN (04))
Program Officer
Shen, Grace L
Project Start
2001-09-01
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2002
Total Cost
$151,500
Indirect Cost
Name
University of California Irvine
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Shieh, Yao Y; Perng, Guey-Chuen (2008) Evaluation of severity of HSV-1 corneal infection by statistical pattern classification technique. Curr Eye Res 33:225-35
Morishige, Naoyuki; Jester, James V; Naito, Julie et al. (2006) Herpes simplex virus type 1 ICP0 localizes in the stromal layer of infected rabbit corneas and resides predominantly in the cytoplasm and/or perinuclear region of rabbit keratocytes. J Gen Virol 87:2817-25
Solbrig, Marylou V; Adrian, Russell; Chang, Daniel Y et al. (2006) Viral risk factor for seizures: pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model. Neurobiol Dis 23:612-20
Naito, Julie; Mott, Kevin R; Osorio, Nelson et al. (2005) Herpes simplex virus type 1 immediate-early protein ICP0 diffuses out of infected rabbit corneas. J Gen Virol 86:2979-88
Barsam, Charles A; Brick, David J; Jones, Clinton et al. (2005) A viral model for corneal scarring and neovascularization following ocular infection of rabbits with a herpes simplex virus type 1 (HSV-1) mutant. Cornea 24:460-6
Naito, Julie; Mukerjee, Ruma; Mott, Kevin R et al. (2005) Identification of a protein encoded in the herpes simplex virus type 1 latency associated transcript promoter region. Virus Res 108:101-10
Peng, Weiping; Henderson, Gail; Inman, Melissa et al. (2005) The locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal Ganglia of acutely infected mice. J Virol 79:6162-71
Jin, Ling; Perng, Guey-Chuen; Brick, David J et al. (2004) Methods for detecting the HSV-1 LAT anti-apoptosis activity in virus infected tissue culture cells. J Virol Methods 118:9-13
Drolet, Barbra S; Mott, Kevin R; Lippa, Andrew M et al. (2004) Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas. Curr Eye Res 29:181-9
Mott, Kevin R; Osorio, Nelson; Jin, Ling et al. (2003) The bovine herpesvirus-1 LR ORF2 is critical for this gene's ability to restore the high wild-type reactivation phenotype to a herpes simplex virus-1 LAT null mutant. J Gen Virol 84:2975-85